NEWS | alsv | Page 3 of 15

Companies in the News

Tempest and Millendo Announce Stockholder Approval of Merger

Tempest to Trade on Nasdaq Public Markets Under Ticker “TPST” SOUTH SAN FRANCISCO, Calif. and ANN ARBOR, Mich., June 22, 2021 (GLOBE...

Lyell Immunopharma Announces Pricing of Initial Public Offering

SOUTH SAN FRANCISCO, Calif., June 16, 2021 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Lyell), (Nasdaq: LYEL), a T cell reprogramming...

MorphoSys to buy Constellation Pharma for $1.7 billion; Constellation's stock soars 61%

Shares of MorphoSys AG ADR MOR, -12.90% were down 8.9% in premarket trading on Wednesday after the company announced a $1.7 billion...

eFFECTOR Therapeutics and Locust Walk Acquisition Corp. Announce Merger Agreement

Gross proceeds expected to include $60 million from a committed PIPE and up to $175 million held in trust Anticipated cash resources will...

Sana Biotechnology Presents Preclinical Data at AACR Meeting 2021

Targeted in vivo gene delivery of a CAR using a CD8-specific fusogen results in tumor eradication Hypoimmune CAR T cells protected from...

Nuvation Bio Granted Orphan Drug Designation for NUV-422 for Patients with Malignant Gliomas

NEW YORK, March 11, 2021 /PRNewswire/ -- Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet...

Vir Biotechnology and GSK Announce VIR-7831 Reduces Hospitalization and Risk of Death in Early Treat

Independent Data Monitoring Committee recommends stopping Phase 3 COMET-ICE trial early given an 85% reduction in hospitalization or...

GlaxoSmithKline doubles down on Vir pact, throwing in $345M upfront to go beyond COVID-19

Last year, Big Pharma GlaxoSmithKline and George Scangos’ biotech Vir joined forces against COVID-19. Now, the pair is turning its...

Nuvation Bio Closes Transaction with Panacea, Debuts as Publicly Traded Oncology Company

Combined company renamed Nuvation Bio Inc., will be listed on the New York Stock Exchange under ticker symbol "NUVB" Strong cash position...